Cevimeline gargle for the treatment of xerostomia in patients with Sjögren's syndrome

Annals of the Rheumatic Diseases

Volumn 63, Issue 6, 2004, Pages 749-

  Takagi, Y ^a   Kimura, Y ^a   Nakamura, T ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CEVIMELINE; CORTICOSTEROID;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRY EYE; FEMALE; FLOW RATE; HUMAN; MEDICAL ASSESSMENT; NAUSEA; PRIORITY JOURNAL; SALIVARY GLAND; SJOEGREN SYNDROME; XEROSTOMIA;

ADMINISTRATION, ORAL; ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTHWASHES; PARASYMPATHOMIMETICS; QUINUCLIDINES; SJOGREN'S SYNDROME; THIOPHENES; XEROSTOMIA;

EID: 2442667938     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2003.012633     Document Type: Article

References (3)

1. Izumi M, Eguchi K, Nakamura H, Takagi Y, Kawabe Y, Nakamura T. Corticosteroid irrigation of parotid gland for treatment of xerostomia in patients with Sjögren's syndrome. Ann Rheum Dis 1998;57:464-9.
2. Petrone D, Condemi JJ, Fife R, Gluck O, Cohen S, Dalgin P. A double-blind, randomized, placebo-controlled study of cevimeline in patients with Sjögren's syndrome with xerostomia and keratoconjunctivitis sicca. Arthritis Rheum 2002;46:748-54.
3. Fox RI, Robinson CA, Curd JG, Kozin F, Howell FV. Sjögren's syndrome: proposed criteria for classification. Arthritis Rheum 1986;29:577-85.